539428 — Tejnaksh Healthcare Income Statement
0.000.00%
- IN₹386.78m
- IN₹379.88m
- IN₹128.97m
- 80
- 49
- 37
- 59
Annual income statement for Tejnaksh Healthcare, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 120 | 127 | 117 | 122 | 129 |
Cost of Revenue | |||||
Gross Profit | 111 | 113 | 103 | 109 | 116 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 89.3 | 85.4 | 87.7 | 93.8 | 97.3 |
Operating Profit | 30.3 | 41.3 | 29.6 | 27.9 | 31.6 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 26.7 | 37.6 | 25.1 | 23.8 | 31.9 |
Provision for Income Taxes | |||||
Net Income After Taxes | 20.7 | 28.1 | 17.9 | 17.6 | 22.3 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 20.5 | 27.2 | 16.8 | 17.8 | 23.3 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 20.5 | 27.2 | 16.8 | 17.8 | 23.3 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.01 | 1.36 | 0.828 | 0.87 | 1.15 |